Join
Live feed
·
NEWSReleasevia Quantisnow
Biolase Inc. logo

Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target

ByQuantisnow·Wall Street's wire, on your screen.
BIOL· Biolase Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIOL (Biolase Inc.) and more on Quantisnow.